The first report of leukocytoclastic vasculitis induced by once-weekly subcutaneous semaglutide.

Autor: Pinheiro MM; UNIVAG, Centro Universitário de Várzea Grande, Várzea Grande, MT, Brazil., de Souza LG; UFMT, Universidade Federal de Mato Grosso, Cuiabá, MT, Brazil., Nunes GP; UNIVAG, Centro Universitário de Várzea Grande, Várzea Grande, MT, Brazil., Martin IF; UNIVAG, Centro Universitário de Várzea Grande, Várzea Grande, MT, Brazil., de Oliveira YU; UNIVAG, Centro Universitário de Várzea Grande, Várzea Grande, MT, Brazil., Pinheiro FMM; Hospital das Clínicas, Faculdade de Medicina de São Paulo, Universidade de São Paulo-USP, São Paulo, SP, Brazil., Costa LN; LAPAT Anatomia Patológica e Citopatologia, Cuiabá, MT, Brazil., Caprio M; Department of Human Sciences and Promotion of the Quality of Life & Laboratory of Cardiovascular Endocrinology, San Raffaele Open University & San Raffaele Research Institute-IRCCS San Raffaele, Rome, Italy., Della-Morte D; Department of Biomedicine and Prevention, Section of Clinical Nutrition and Nutrigenomics, University of Rome Tor Vergata, Rome, Italy., Infante M; Section of Diabetes & Metabolic Disorders, UniCamillus, Saint Camillus International University of Health Sciences, Rome, Italy.

Publikováno v: Current medical research and opinion [Curr Med Res Opin] 2024 Sep; Vol. 40 (9), pp. 1525-1531. Date of Electronic Publication: 2024 Aug 02.

Type 1 diabetes prevention and treatment: Time to think outside the box.

Autor: Pinheiro MM; UNIVAG, Centro Universitário, Várzea Grande, Brazil., Pinheiro FMM; Faculdade de Medicina de São Paulo, Hospital das Clínicas, São Paulo, Brazil.

Publikováno v: Journal of diabetes [J Diabetes] 2023 Dec; Vol. 15 (12), pp. 1107-1108. Date of Electronic Publication: 2023 Nov 13.

Association between sitagliptin plus vitamin D3 (VIDPP-4i) use and clinical remission in patients with new-onset type 1 diabetes: a retrospective case-control study.

Autor: Pinheiro MM; Univag Centro Universitário, Várzea Grande, MT, Brasil, marcelo.pinheiro@univag.edu.br.; Universidade Anhanguera, São Paulo, SP, Brasil.; Beta Cell Center Diabetes & Endocrinologia, Cuiabá, MT, Brasil., Pinheiro FMM; Hospital das Clínicas, Faculdade de Medicina de São Paulo, Universidade de São Paulo, São Paulo, SP, Brasil., de Arruda MM; Hospital Universitário Júlio Müller, Cuiabá, MT, Brasil., Beato GM; Beta Cell Center Diabetes & Endocrinologia, Cuiabá, MT, Brasil., Verde GACL; Universidade de Cuiabá (Unic), Cuiabá, MT, Brasil.; Univag Centro Universitário, Várzea Grande, MT, Brasil., Bianchini G; Clínica Hortênsia, Sinop, MT, Brasil., Casalenuovo PRM; Escola Paulista de Medicina, Universidade Federal de São Paulo (Unifesp), São Paulo, SP, Brasil., Argolo AAA; Clínica Instituto da Visão, Tangará da Serra, MT, Brasil., de Souza LT; Medclin, Rondonópolis, MT, Brasil., Pessoa FG; Suprema Clínica e Diagnóstico, Rondonópolis, MT, Brasil., Hirose TS; Centro Universitário Estácio de Ribeirão Preto, Ribeirão Preto, SP, Brasil., Senra EF; Endocrinoclinica, Joinville, SC, Brasil., Ricordi C; Diabetes Research Institute (DRI) and Cell Transplant Center, University of Miami Miller School of Medicine, Miami, FL, USA., Fabbri A; Diabetes Research Institute Federation (DRIF), Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy., Infante M; Diabetes Research Institute (DRI) and Cell Transplant Center, University of Miami Miller School of Medicine, Miami, FL, USA.; Diabetes Research Institute Federation (DRIF), Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.; Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Rome, Italy.; UniCamillus, Saint Camillus International University of Health Sciences, Rome, Italy., Diniz SN; Universidade Anhanguera, São Paulo, SP, Brasil, susana.diniz@platosedu.com.br.

Publikováno v: Archives of endocrinology and metabolism [Arch Endocrinol Metab] 2023 May 25; Vol. 67 (5), pp. e000652.

Combination of vitamin D and dipeptidyl peptidase-4 inhibitors (VIDPP-4i) as an immunomodulation therapy for autoimmune diabetes.

Autor: Pinheiro MM; UNIVAG, University Center, Dom Orlando Chaves Ave, 2655 - Cristo Rei, Várzea Grande, 78118-000 Mato Grosso, Brazil; Universidade Anhanguera de São Paulo - SP, 3305, Raimundo Pereira de Magalhães Ave., Pirituba, São Paulo, 05145-200 São Paulo, Brazil. Electronic address: marcelo.pinheiro@univag.edu.br., Pinheiro FMM; Hospital de Base, Faculdade de Medicina de São José do Rio Preto FAMERP - SP, 5546, Brigadeiro Faria Lima Ave, Vila São Pedro, São José do Rio Preto, 15015-500 São Paulo, Brazil., Diniz SN; Universidade Anhanguera de São Paulo - SP, 3305, Raimundo Pereira de Magalhães Ave., Pirituba, São Paulo, 05145-200 São Paulo, Brazil., Fabbri A; Diabetes Research Institute Federation (DRIF), Division of Endocrinology and Diabetes, CTO Andrea Alesini Hospital, ASL Roma 2, Department of Systems Medicine, University of Rome Tor Vergata, Via San Nemesio 21, 00145 Rome, Italy., Infante M; Diabetes Research Institute Federation (DRIF), Division of Endocrinology and Diabetes, CTO Andrea Alesini Hospital, ASL Roma 2, Department of Systems Medicine, University of Rome Tor Vergata, Via San Nemesio 21, 00145 Rome, Italy; UniCamillus, Saint Camillus International University of Health Sciences, Via di Sant'Alessandro, 8, 00131 Rome, Italy; Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Via San Nemesio 21, 00145 Rome, Italy. Electronic address: marco.infante@unicamillus.org.

Publikováno v: International immunopharmacology [Int Immunopharmacol] 2021 Jun; Vol. 95, pp. 107518. Date of Electronic Publication: 2021 Mar 20.